Literature DB >> 26915266

Whole-exome sequencing for relapse prediction in patients discontinuing TKI treatment in chronic myeloid leukemia.

Sameem Abedin1, Leonidas C Platanias1,2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26915266     DOI： 10.3109/10428194.2016.1151514

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  1 in total

1.  Spred-3 mutation and Ras/Raf/MAPK activation confer acquired resistance to EGFR tyrosine kinase inhibitor in an EGFR mutated NSCLC cell line.

Authors:  Zhiyong He; Fusheng Gong; Jinrong Liao; Qiang Wang; Ying Su; Chao Chen; Jinghui Lin; Ren-Jang Lin
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.